BALMER LAWRIE
Indian Markets were closed today(02-04-2015) on the occasion of Mahavir Jayanti. Following our promise to make money for you even in a closed market. Here's a multibagger stock that can resize your portfolio into a king size; Balmer Lawrie.
Yes, Balmer Lawrie Compant Ltd. is a multiactivity company. It has a diversified business portfolio from Packaging to Logistics Infrastructure , from Grease and Lubricants to Engineering and Technology. Balmer Lawrie has struck the right note every time. Let us see why Balmer Lawrie can make your portfolio shine.
FOUR simple straight reasons:
CMP:576
PE for the company is 10.96 as compared to industry PE of 16.84 which makes it a cheap bet inspite of the run it has shown.
Yes, Balmer Lawrie Compant Ltd. is a multiactivity company. It has a diversified business portfolio from Packaging to Logistics Infrastructure , from Grease and Lubricants to Engineering and Technology. Balmer Lawrie has struck the right note every time. Let us see why Balmer Lawrie can make your portfolio shine.
FOUR simple straight reasons:
CMP:576
VALUATION
|
BALANCE
SHEET
|
PARENTAGE
|
FUTURE
OUTLOOK
|
1.FACE
VALUE: 10
|
1. DIVIDEND YIELD: 180%
|
1.PROMOTER: 0%
|
1. GST.
|
2.MARKET
CAPITAL: 1638.5 CR
|
2.DEBT: 0
|
2.FII: 3.40%
|
2. DEFENSE EXPENDITURE.
|
3.PE:
10.96
|
3.ASSETS: 819.64 CR
|
3.DII: 11.33%
|
3. STRONG MANAGEMENT.
|
4.BOOK
VALUE: 287.59
|
4.EQUITY SHARE CAPITAL: 28.50 CR
|
4. OTHER: 85.27%
|
4. MAKE IN INDIA.
|
5.EPS:
52.46
|
5.RESERVES: 791.14 CR
|
||
6.INDUSTRY
PE: 16.84
|
A zero debt company with Reserves= 27.7*ESC makes it a good bet.
Parentage of the company is quite strong with Parent company, Balmer Lawrie and Investment holding a big chunk of 61.8% of total capital. Also FII's have increased their stake to 3.40% in December quarter 2014 as compared to 1.56% in March 2014.
Introduction of GST, increased defense expenditure and ambitious Make In India coupled with a strong management indicate better days for the stock ahead with targets of above 1000 and much more.
No comments:
Post a Comment